BACKGROUND: seed powder solution on the lipid profile of newly diagnosed type II diabetic patients. METHODS: = 57) which receives metformin. Blood sample was collected from each participant by a medical technologist/technician before and after the study. Lipid profile was analyzed by using Mindray BS 200E fully automated clinical chemistry analyzer. RESULT: < 0.001). However, lipid profile levels in the control group were not significantly changed. CONCLUSION: seed may provide new alternatives for the clinical management of type II diabetes.
No takes yet. Share an insight, caveat, or question.
Geberemeskel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: